NGD-4715
id:
ngd-4715-243-4988772
title:
NGD-4715
text:
NGD-4715 is a drug developed by Neurogen, which acts as a selective, non-peptide antagonist at the melanin concentrating hormone receptor MCH1. In animal models it has anxiolytic, antidepressant, and anorectic effects, and it has successfully passed Phase I clinical trials in humans. Neurogen was acquired by Ligand Pharmaceuticals in August, 2009, and NGD-4715 was not listed among its key assets. All four laboratories were closed and sold, and no employees were retained. The structure of NGD-471
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/NGD-4715
date created:
date modified:
2023-12-03T22:20:04Z
main entity:
{"identifier":"Q63210360","url":"https://www.wikidata.org/entity/Q63210360"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/4/48/NGD-4715.svg","width":875,"height":485}
fields total:
13
integrity:
15